Editorial & Opinion
Response to "DPYD genotyping panels: Impact of population diversity".
| العنوان: | Response to "DPYD genotyping panels: Impact of population diversity". |
|---|---|
| المؤلفون: | Gaedigk A; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute (CMRI), Kansas City, Missouri, USA., Turner AJ; RPRD Diagnostics LLC, Milwaukee, Wisconsin, USA., Haidar CE; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Empey PE; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA., Offer SM; Department of Pathology, University of Iowa, Iowa City, Iowa, USA. |
| المصدر: | Clinical and translational science [Clin Transl Sci] 2024 Apr; Vol. 17 (4), pp. e13806. |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Malden, MA : WileyBlackwell Pub., 2008- |
| مواضيع طبية MeSH: | Fluorouracil*, Humans ; Genotype ; Capecitabine |
| References: | Clin Transl Sci. 2024 Jan;17(1):e13699. (PMID: 38129972) |
| المشرفين على المادة: | U3P01618RT (Fluorouracil) 6804DJ8Z9U (Capecitabine) |
| تواريخ الأحداث: | Date Created: 20240419 Date Completed: 20240422 Latest Revision: 20240422 |
| رمز التحديث: | 20240422 |
| مُعرف محوري في PubMed: | PMC11026573 |
| DOI: | 10.1111/cts.13806 |
| PMID: | 38637962 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1752-8062 |
|---|---|
| DOI: | 10.1111/cts.13806 |